ClinicalTrials.gg
RecruitingNCT07467694PEABaByUpdated Mar 12, 2026

Postnatal Exercise to Activate Baby's Brown Fat

An interventional study of Active group in Childhood Obesity Prevention, Childhood Obesity and Physical Activity, sponsored by Joslin Diabetes Center. Recruiting at 2 sites in United States. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Joslin Diabetes Center · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The purpose of this study is to learn how exercise and physical activity during pregnancy and after pregnancy may affect the composition of breastmilk. Certain changes in breast milk after exercise may have an impact on how infants use energy. Understanding this process may improve public health recommendations for exercise during and after pregnancy. This study can help investigators learn more about how maternal exercise patterns may affect body growth and obesity risk in infants who are breastfed. This research may help identify how different factors can influence healthy weight and early development in infants.

Read the detailed description

Epidemiological studies suggest that breastfeeding protects against risk of obesity, diabetes, asthma, and other childhood diseases. However, the specific compounds within breastmilk that are responsible for its protective effects are not fully understood. Moreover, prior work from this investigative team has shown that human milk composition varies substantially between individuals according to factors such as body mass index (BMI), diabetes status, diet, and physical activity. Gaining a better understanding of how modifiable risk factors may impact human milk composition would have the potential to identify strategies to enhance the health-promoting benefits of human milk.

In this project, the investigators will study the impact of maternal exercise on human milk composition. The central hypothesis is that maternal exercise induces changes in breast milk metabolites and lipids that result in activation of infant brown fat, increased infant energy expenditure, and reduced obesity risk.

The study will include assessments of habitual activity during pregnancy and the postpartum period, supervised bouts acute moderate exercise, as well as analysis of human milk composition, infant growth and body composition, and infant energy expenditure.

02

Conditions studied

  • Childhood Obesity Prevention
  • Childhood Obesity
  • Physical Activity
  • Lactation
  • Breastfeeding
  • Pregnancy
  • Exercise

Keywords

  • Lactation
  • Breastfeeding
  • Breast milk
  • Pregnancy
  • Exercise
03

In context

Pediatric Obesity

1,129 studies on the registry are indexed under Pediatric Obesity; 187 are open to participants now.

This study's planned enrollment of 200 is above the median of 100 across 870 interventional studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

Joslin Diabetes Center is the lead sponsor of 80 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-45 y of age at the time of enrollment
  • Pre-gravid or first trimester 18.5 -40 kg/m2
  • Uncomplicated singleton pregnancy
  • Intention to exclusively breastfeed for >3 months and, if parity >1, that they successfully breastfed a previous pregnancy
  • Term pregnancy (gestational age 37 to \<42 weeks)
  • Infant with birth weight >10th percentile of weight for gestational age

Exclusion criteria

Exclusion Criteria:

  • Any obstetric to exercise at 1 month
  • Diagnosis of uncontrolled ( >7%) type 1 or type 2 diabetes, or gestational diabetes managed with insulin
  • Intrauterine growth restriction
  • Pre-eclampsia or other pregnancy complications
  • Alcohol, cannabis or tobacco use
  • Known congenital metabolic, endocrine disease, or congenital illness affecting infant feeding/growth
  • Major fetal anomalies
  • Musculoskeletal issues that would make exercise difficult
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Enhanced physical activity

    Participants in this group will be encouraged to engage in daily physical activity

    Behavioral: Active group

  • No intervention
    Control group

    Usual care

Interventions

  • BehavioralActive group

    For participants randomized to the Active group, there will be weekly phone calls with study staff during which step counts and exercise bouts from the previous week will be reviewed, and exercise goals for the following week will be gradually increased.

06

What researchers measure

Primary outcomes

  1. Altered breast milk lipidome

    Milk composition measured through lipidomics

    Time frame: 8 weeks

  2. Altered breast milk metabolome

    Human milk composition measured via metabolomics

    Time frame: 8 weeks

Secondary outcomes

  1. Infant body composition

    Infant body composition will be measured using air-displacement plethysmography (ADP; i.e., PeaPod) at 1 and 3-mo and by DXA at 6 and 12-mo: percentage fat, total fat mass.

    Time frame: 3 months, 6 months, and 12 months

  2. Infant body mass index (BMI)

    Body mass index (BMI) z-score for age and sex, usual range \[-4,4\]; lower BMI z-score represents lower adiposity

    Time frame: 3 months, 6 months, and 12 months

  3. Infant resting metabolic rate

    Infant Resting Metabolic Rate

    Time frame: 3 months of age

Other outcomes

  1. Infant brown adipose tissue anatomy

    MRI measurement of brown adipose tissue (BAT) volume and distribution

    Time frame: 2 months

  2. Heat production

    Infant Infrared Thermography to measure brown adipose tissue activity

    Time frame: 1 month and 3 months

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07467694
Lead sponsor
Joslin Diabetes Center
Responsible party
Sponsor
First posted
Mar 12, 2026
Start date
Dec 1, 2025
Primary completion
Jul 1, 2030 (estimated)
Completion
Jul 1, 2030 (estimated)
Last update
Mar 12, 2026

Study contacts

Elvira M Isganaitis, MD, MPH
Contact
elvira.isganaitis@joslin.harvard.edu
617-309-4554
Study Coordinator
Contact
PeaBaBy@joslin.harvard.edu
857-289-3455

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion